Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

Clinical trial NCT05286294 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05286294
Sponsor: Oslo University Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Stage IV Head and Neck Squamous Cell Carcinoma Cutaneous Squamous Cell Carcinoma MSI-High Clear Cell Renal Cell Carcinoma Non-small Cell Lung Cancer

Start date: 2022-06-28
Primary completion: 2034-03-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.